Intuitive Surgical, Inc. $ISRG Shares Sold by Candriam S.C.A.

Candriam S.C.A. lowered its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 19.0% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 270,080 shares of the medical equipment provider’s stock after selling 63,466 shares during the period. Intuitive Surgical comprises about 0.6% of Candriam S.C.A.’s holdings, making the stock its 29th largest position. Candriam S.C.A.’s holdings in Intuitive Surgical were worth $120,788,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Tobam grew its position in shares of Intuitive Surgical by 666.7% during the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 40 shares during the last quarter. Kilter Group LLC purchased a new stake in shares of Intuitive Surgical in the second quarter valued at about $27,000. Greykasell Wealth Strategies Inc. acquired a new stake in shares of Intuitive Surgical during the third quarter worth about $27,000. Princeton Global Asset Management LLC purchased a new position in shares of Intuitive Surgical during the second quarter worth about $30,000. Finally, Guerra Advisors Inc acquired a new position in Intuitive Surgical in the 3rd quarter valued at about $37,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of analysts have weighed in on the company. Piper Sandler reaffirmed an “overweight” rating and set a $620.00 price objective (up from $610.00) on shares of Intuitive Surgical in a research report on Friday, January 23rd. Raymond James Financial increased their price target on Intuitive Surgical from $603.00 to $615.00 and gave the stock an “outperform” rating in a report on Friday, January 23rd. Weiss Ratings reissued a “hold (c+)” rating on shares of Intuitive Surgical in a research note on Monday, December 29th. UBS Group restated a “neutral” rating on shares of Intuitive Surgical in a research report on Thursday, January 15th. Finally, Wells Fargo & Company lifted their target price on shares of Intuitive Surgical from $600.00 to $654.00 and gave the company an “overweight” rating in a report on Friday, December 12th. One research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $617.23.

Intuitive Surgical Stock Performance

ISRG opened at $488.15 on Monday. The company has a market cap of $173.36 billion, a price-to-earnings ratio of 61.87, a PEG ratio of 3.79 and a beta of 1.65. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $609.08. The business’s fifty day moving average is $549.63 and its two-hundred day moving average is $510.60.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The firm had revenue of $2.87 billion for the quarter, compared to analysts’ expectations of $2.72 billion. During the same period in the prior year, the company earned $2.21 EPS. The firm’s revenue was up 18.8% on a year-over-year basis. On average, analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, EVP Myriam Curet sold 126 shares of the stock in a transaction on Thursday, January 29th. The stock was sold at an average price of $520.02, for a total transaction of $65,522.52. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Gary S. Guthart sold 2,800 shares of the company’s stock in a transaction on Tuesday, January 27th. The shares were sold at an average price of $531.52, for a total value of $1,488,256.00. Following the completion of the sale, the director owned 15,720 shares in the company, valued at $8,355,494.40. This represents a 15.12% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 70,011 shares of company stock worth $38,858,275 in the last quarter. Insiders own 0.70% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.